Clinical usefulness of eight novel monoclonal antibodies against prostate-specific antigen (PSA) to differentiate prostate cancer and benign prostate hyperplasia. Measurement of different PSA molecular forms with specific immunoassays

Autor:	Francisco España, Manuel Martínez-Sarmiento, J. Oto, Montserrat Royo, Laura Martos, S. Navarro, L.A. Ramón, C.D. Vera Donoso, J.M. Alapont, P. Medina-Badenes
Rok vydání:	2017
Předmět:	PCA3 Prostate cancer Prostate-specific antigen business.industry medicine.drug_class Urology Cancer research Medicine Hyperplasia business medicine.disease Monoclonal antibody Benign prostate
Zdroj:	European Urology Supplements. 16:e615
ISSN:	1569-9056
DOI:	10.1016/s1569-9056(17)30413-x
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9ab2c075a3e916f7c70f8a55318d982b https://doi.org/10.1016/s1569-9056(17)30413-x Zobrazit plný text záznamu Full Text from ScienceDirect